Pall T. Onundarson, Ragnar Palsson, Daniel M. Witt & Brynja R. Gudmundsdottir. (2021) Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article. Thrombosis Journal 19:1.
Crossref
Abolarin Ademola Toyosi, Olawumi Hannah Oluwayemisi, Durotoye Idayat Adenike, Olarinoye John Kola & Olufemi-Aworinde Kehinde Joyce. (2021) Assessment of coagulation and fibrinolytic factors among patients with type 2 diabetes mellitus in University of Ilorin Teaching Hospital, Ilorin, Nigeria. Annals of Clinical and Biomedical Research 2:1.
Crossref
Cecil Reuben Ross, Sitalakshmi Subramanian, Jordi Navarro-Puerto, Kannan Subramanian, Nijalingappa K. Kalappanavar, Claudia Djambas Khayat, Suchitra S. Acharya, Flora Peyvandi, Karen Rucker, Wei Liang, David Vilardell, Sabile Trimm & Jaume Ayguasanosa. (2021) Pharmacokinetics, surrogate efficacy and safety evaluations of a new human plasma-derived fibrinogen concentrate (FIB Grifols) in adult patients with congenital afibrinogenemia. Thrombosis Research 199, pages 110-118.
Crossref
Klaus Görlinger, Tetsuro Sakai, Daniel Dirkmann, Raymond M. Planinsic, Khaled Yassen & Fuat H. Saner. 2021. Management of Bleeding Patients. Management of Bleeding Patients
339
359
.
Marcus Fager Ferrari, Eva Leinoe, Maria Rossing, Eva Norström & Eva Zetterberg. (2020) A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family. Blood Coagulation & Fibrinolysis 31:7, pages 481-484.
Crossref
Pall T. Onundarson & Brynja R. Gudmundsdottir. (2019) The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin. Journal of Thrombosis and Thrombolysis 48:4, pages 685-689.
Crossref
Sean G. Yates, Eric Fitts, Nicole De Simone & Ravi Sarode. (2019) Prolonged partial thromboplastin time: To mix or not to mix – is that the question?. Transfusion and Apheresis Science 58:1, pages 39-42.
Crossref
Daniel Dirkmann. 2019. Critical Care for Potential Liver Transplant Candidates. Critical Care for Potential Liver Transplant Candidates
101
118
.
Piet Meijer, Karin Kynde, Antonius M.H.P. van den Besselaar, Marjan Van Blerk & Timothy A.L. Woods. (2018) International normalized ratio (INR) testing in Europe: between-laboratory comparability of test results obtained by Quick and Owren reagents. Clinical Chemistry and Laboratory Medicine (CCLM) 56:10, pages 1698-1703.
Crossref
R. Zenlander, M. von Euler, J. Antovic & A. Berglund. (2017)
Point‐of‐care versus central laboratory testing of
INR
in acute stroke
. Acta Neurologica Scandinavica 137:2, pages 252-255.
Crossref
Hayrullah Yazar, Fatma Özdemir & Elif Köse. (2018) Effect of Centrifuge Temperature on Routine Coagulation Tests. Acta Haematologica 139:3, pages 158-163.
Crossref
Kathleen Brummel-Ziedins & Kenneth G. Mann. 2018. Hematology. Hematology
1885
1905.e8
.
S. Benediktsson, A. Frigyesi & T. Kander. (2017) Routine coagulation tests on ICU admission are associated with mortality in sepsis: an observational study. Acta Anaesthesiologica Scandinavica 61:7, pages 790-796.
Crossref
Alma Rut Oskarsdóttir, Brynja R. Gudmundsdottir, Olafur S. Indridason, Sigrun H. Lund, David O. Arnar, Einar S. Bjornsson, Magnus K. Magnusson, Hulda M. Jensdottir, Brynjar Vidarsson, Charles W. Francis & Pall T. Onundarson. (2017) Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial. Journal of Thrombosis and Thrombolysis 43:4, pages 550-561.
Crossref
P.I. Jonsson, L. Letertre, S.J. Juliusson, B.R. Gudmundsdottir, C.W. Francis & P.T. Onundarson. (2017) During warfarin induction, the Fiix‐prothrombin time reflects the anticoagulation level better than the standard prothrombin time. Journal of Thrombosis and Haemostasis 15:1, pages 131-139.
Crossref
A. Tripodi, B. de Laat, D. Wahl, W. Ageno, B. Cosmi & M. Crowther. (2016) Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis 14:11, pages 2304-2307.
Crossref
P. T. Onundarson, D. O. Arnar, S. H. Lund, B. R. Gudmundsdottir, C. W. Francis & O. S. Indridason. (2016) Fiix-prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin. International Journal of Laboratory Hematology 38, pages 78-90.
Crossref
M.J. Beinema, F.J.M. van der Meer, J.R.B.J. Brouwers & F.R. Rosendaal. (2016) Optimization of vitamin K antagonist drug dose finding by replacement of the international normalized ratio by a bidirectional factor: validation of a new algorithm. Journal of Thrombosis and Haemostasis 14:3, pages 479-484.
Crossref
Fuat H. Saner & Carmen Kirchner. (2016) Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease. Visceral Medicine 32:4, pages 241-248.
Crossref
Klaus Görlinger, Tetsuro Sakai, Daniel Dirkmann, Raymond M. Planinsic & Fuat H. Saner. 2016. Management of Bleeding Patients. Management of Bleeding Patients
263
280
.
Páll T Onundarson, Charles W Francis, Olafur S Indridason, David O Arnar, Einar S Bjornsson, Magnus K Magnusson, Sigurdur J Juliusson, Hulda M Jensdottir, Brynjar Vidarsson, Petur S Gunnarsson, Sigrun H Lund & Brynja R Gudmundsdottir. (2015) Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial. The Lancet Haematology 2:6, pages e231-e240.
Crossref
Klaus Görlinger, Eva Schaden & Fuat H. Saner. 2015. Perioperative Hemostasis. Perioperative Hemostasis
267
283
.
Kathleen E. Brummel-Ziedins & Alisa S. Wolberg. (2014) Global assays of hemostasis. Current Opinion in Hematology 21:5, pages 395-403.
Crossref
Kathleen E. Brummel-Ziedins, Stephen J. Everse, Kenneth G. Mann & Thomas Orfeo. (2013) Modeling thrombin generation: plasma composition based approach. Journal of Thrombosis and Thrombolysis 37:1, pages 32-44.
Crossref
Geoffrey D. Wool & Chuanyi M. Lu. (2013) Pathology Consultation on Anticoagulation Monitoring. American Journal of Clinical Pathology 140:5, pages 623-634.
Crossref
K. Brummel‐Ziedins. (2013) Models for thrombin generation and risk of disease. Journal of Thrombosis and Haemostasis 11, pages 212-223.
Crossref
Brynja R. Gudmundsdottir, Charles W. Francis, Alexia M. Bjornsdottir, Moa Nellbring & Pall T. Onundarson. (2012) Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time. Thrombosis Research 130:4, pages 674-681.
Crossref
Mattias Wieloch, Andreas Hillarp, Karin Strandberg, Camilla Nilsson & Peter J. Svensson. (2009) Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin. Thrombosis Research 124:3, pages 344-348.
Crossref
Adam J. Rose, Dan R. Berlowitz, Susan M. Frayne & Elaine M. Hylek. (2009) Measuring Quality of Oral Anticoagulation Care: Extending Quality Measurement to a New Field. The Joint Commission Journal on Quality and Patient Safety 35:3, pages 146-155.
Crossref
P. T. ONUNDARSON, K. A. EINARSDOTTIR & B. R. GUDMUNDSDOTTIR. (2008) Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice. International Journal of Laboratory Hematology 30:5, pages 382-389.
Crossref
Henrik Arnell, Sven Bergdahl, Nikos Papadogiannakis, Antal Nemeth & Björn Fischler. (2008) Preoperative observations and short-term outcome after partial external biliary diversion in 13 patients with progressive familial intrahepatic cholestasis. Journal of Pediatric Surgery 43:7, pages 1312-1320.
Crossref
Evangelos Kalaitzakis, Rolf Olsson, Pia Henfridsson, Irene Hugosson, Maria Bengtsson, Rajiv Jalan & Einar Björnsson. (2007) Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver International 0:0, pages 070901081846004-???.
Crossref
Gunnar Nilsson, Karin Strandberg, Jan Astermark, Einar Vernersson, Johan Stenflo & Erik Berntorp. (2007) The APC–PCI complex concentration predicts outcome of aortic surgery. Thrombosis Research 120:2, pages 237-244.
Crossref
A. OSMAN, C. ENSTRÖM, K. ARBRING, P. SÖDERKVIST & T.L. LINDAHL. (2006) Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records. Journal of Thrombosis and Haemostasis 4:8, pages 1723-1729.
Crossref
Tomi T Niemi, Edward Munsterhjelm, Reino Pöyhiä, Marja S Hynninen & Markku T Salmenperä. (2006) The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagulation & Fibrinolysis 17:1, pages 29-34.
Crossref
J Rem, C Feddersen, M R Brandt & H Kehlet. (1981) Postoperative changes in coagulation and fibrinolysis independent of neurogenic stimuli and adrenal hormones. British Journal of Surgery 68:4, pages 229-233.
Crossref
Sajja Suchitra & Paritosh Joshi. (2005) Characterization of Haemonchus contortus calreticulin suggests its role in feeding and immune evasion by the parasite. Biochimica et Biophysica Acta (BBA) - General Subjects 1722:3, pages 293-303.
Crossref
Gunnar Nilsson, Jan Astermark, Stefan Lethagen, Einar Vernersson & Erik Berntorp. (2005) Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survival. Thrombosis Research 116:1, pages 15-24.
Crossref
Stefan C. Carlsson, Christer Mattsson, Ulf G. Eriksson, Troy C. Sarich, Karin Wåhlander, Åsa Eliasson, Björn W. Karlson, Sunita B. Sheth & Peter Held. (2005) A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays. Thrombosis Research 115:1-2, pages 9-18.
Crossref
Magnus Jonsson, Andreas Hillarp & Peter Svensson. (2004) Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy. Thrombosis Research 114:2, pages 83-89.
Crossref
Susanne Johansson, Karin Wåhlander, Göran Larson, Lis Ohlsson, Marita Larsson & Ulf G Eriksson. (2003) Pharmacokinetics and anticoagulant effect of the direct thrombin inhibitor melagatran following subcutaneous administration to healthy young men. Blood Coagulation & Fibrinolysis 14:7, pages 677-684.
Crossref
S. Chan, M. Kong, D.M. Minning, U. Hedner & V.J. Marder. (2003) Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin. Journal of Thrombosis and Haemostasis 1:4, pages 760-765.
Crossref
G. Nilsson, J. Astermark, S. Lethagen, E. Vernersson & E. Berntorp. (2002) The prognostic value of global haemostatic tests in the intensive care unit setting. Acta Anaesthesiologica Scandinavica 46:9, pages 1062-1067.
Crossref
Armando Tripodi, Veena Chantarangkul, Marigrazia Clerici, Barbara Negri, Monica Galli & Pier Mannuccio Mannucci. (2001) Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. British Journal of Haematology 115:3, pages 672-678.
Crossref
T. T. Niemi, M. Pitkänen, M. Syrjälä & P. H. Rosenberg. (2001)
Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty
Note
. Acta Anaesthesiologica Scandinavica 44:4, pages 457-464.
Crossref
T. T. Niemi, J. T. Backman, M. T. Syrjälä, L. U. Viinikka & P. H. Rosenberg. (2001) Platelet dysfunction after intravenous ketorolac or propacetamol. Acta Anaesthesiologica Scandinavica 44:1, pages 69-74.
Crossref
K.M Hansson, T.P Vikinge, M Rånby, P Tengvall, I Lundström, K Johansen & T.L Lindahl. (1999) Surface plasmon resonance (SPR) analysis of coagulation in whole blood with application in prothrombin time assay. Biosensors and Bioelectronics 14:8-9, pages 671-682.
Crossref
Mats RÅnby, Tony Gojceta, Kerstin Gustafsson, Kenny M Hansson & Tomas L Lindahl. (1999) Isocitrate as Calcium Ion Activity Buffer in Coagulation Assays. Clinical Chemistry 45:8, pages 1176-1180.
Crossref
L. Poller. 1999. Laboratory Techniques in Thrombosis - a Manual. Laboratory Techniques in Thrombosis - a Manual
45
61
.
Douglas A. Triplett. (1998) CURRENT RECOMMENDATIONS FOR WARFARIN THERAPY. Medical Clinics of North America 82:3, pages 601-611.
Crossref
S.M. Lavelle & Maura Mhic Iomhair. (1996) THE QUANTITATIVE REDUCTION BY ACUTE-DOSE WARFARIN OF VENOUS THROMBOSIS IN NORMAL AND HYPERTHROMBOTIC RATS. Thrombosis Research 84:6, pages 411-417.
Crossref
Ariella Zivelin, L.Vijaya Mohan Rao & Samuel I. Rapaport. (1996) Plasma PIVKA proteins in rabbits given warfarin. Thrombosis Research 82:5, pages 429-438.
Crossref
. (1996) Fachmitteilung. LaboratoriumsMedizin 20:7-8, pages 443-456.
Crossref
. (1995) Thrombosis in the Antiphospholipid-Antibody Syndrome. New England Journal of Medicine 333:10, pages 665-667.
Crossref
Elisabeth MoorAngela SilveiraFerdinand van’t HooftAnna Maija SuontakaPer ErikssonMargareta BlombäckAnders Hamsten. (1995) Coagulation Factor VII Mass and Activity in Young Men With Myocardial Infarction at a Young Age. Arteriosclerosis, Thrombosis, and Vascular Biology 15:5, pages 655-664.
Crossref
Matti Vuoristo, Martti Fäarkkilä, Anna-Liisa Karvonen, Rauli Leino, Juhani Lehtola, Judit Mäkinen, Jorma Mattila, Claes Friman, Kari Seppälä, Juhani Tuominen & Tatu A. Miettinen. (1995) A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology 108:5, pages 1470-1478.
Crossref
Eva Marie T. Erfurth, Ulla‐Brltt C. Ericsson, Karln Egervall & Stefan R. Lethagen. (2008) Effect of acute desmopressin and of long‐term thyroxine replacement on haemostasis in hypothyroidism. Clinical Endocrinology 42:4, pages 373-378.
Crossref
Paul Sun, Jane Hata, John Bauer, Carolyn Haibach, Doug Campbell, Medhi Farhangi & Dan Smith. (2006) A functional factor X deficiency. American Journal of Hematology 48:1, pages 1-4.
Crossref
W. THEISS. (2006) Anticoagulants: When and How?. Pacing and Clinical Electrophysiology 17:5, pages 1011-1015.
Crossref
A SilveiraF KarpeM BlombäckG SteinerG WalldiusA Hamsten. (1994) Activation of coagulation factor VII during alimentary lipemia.. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 14:1, pages 60-69.
Crossref
G. Ramström, S. Sindet-Pedersen, G. Hall, M. Blombäck & U. Älander. (1993) Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. Journal of Oral and Maxillofacial Surgery 51:11, pages 1211-1216.
Crossref
FINN STENER JØRGENSEN, PETER FELDING, SØREN VINTHER & GUNNAR EG ANDERSEN†. (2008)
Vitamin K to Neonates:
Peroral versus Intramuscular Administration
. Acta Paediatrica 80:3, pages 304-307.
Crossref
J. Duchateau, A. Nevelsteen, R. Suy, R. Demeyere, J. Vandecraen, M. Goossens, M. Bogaerts, J. Arnout & J. Vermylen. (1990) Autotransfusion during aorto-iliac surgery. European Journal of Vascular Surgery 4:4, pages 349-354.
Crossref
L. Ovesen, S. Lyduch & P. Ott. (1989) A simple technique for predicting maintenance dosage of warfarin — Is it better than empirical dosing?. European Journal of Clinical Pharmacology 37:6, pages 573-576.
Crossref
Monica Galli, Suzette Béguin, Theo Lindhout & Coenraad H. Hemker. (1989) Inhibition of phospholipid and platelet-dependent prothrombinase activity in the plasma of patients with lupus anticoagulants. British Journal of Haematology 72:4, pages 549-555.
Crossref
Henrik E. Poulsen & Per Thomsen. (2008) Long‐term administration of toxic doses of paracetamol (acetaminophen) to rats. Liver 8:3, pages 151-156.
Crossref
L. Jørgensen, P. Thomsen & H. E. Poulsen. (2009) Disulfiram Prevents Acetaminophen Hepatotoxicity in Rats. Pharmacology & Toxicology 62:5, pages 267-271.
Crossref
E. H. J. Smeets & J. W. J. van Wersch. (1988) Automation of the Prothrombin Time Assay on a Centrifugal Analyser Using Two Different Chromogenic Substrate Reagents. Clinical Chemistry and Laboratory Medicine 26:12.
Crossref
Leon Poller. 1987. The New Dimensions of Warfarin Prophylaxis. The New Dimensions of Warfarin Prophylaxis
95
112
.
Amy D. Shapiro, Linda J. Jacobson, Mary E. Armon, Marilyn J. Manco-Johnson, Peter Hulac, Peter A. Lane & Wm.E. Hathaway. (1986) Vitamin K deficiency in the newborn infant: Prevalence and perinatal risk factors. The Journal of Pediatrics 109:4, pages 675-680.
Crossref
K. DALAKER. (2005) Clotting factor VII during pregnancy, delivery and puerperium. BJOG: An International Journal of Obstetrics & Gynaecology 93:1, pages 17-21.
Crossref
H. E. POULSEN, J. GAUB & J. IVERSEN. (2008) Changes in quantitative measures of hepatic function after 90% hepatectomy in rats. European Journal of Clinical Investigation 15:5, pages 285-289.
Crossref
ERLING TVEDEGAARD, HENRIK ENGHUSEN POULSEN, HENRIK VILSTRUP & HENRIK KLEM THOMSEN. (2008) Functional status of the liver during chronic renal failure: an experimental study in the rabbit. Liver 5:4, pages 183-188.
Crossref
PJ Neuvonen, A. Jaakkola, J. Totterman & O. Penttila. (2012) Clinically significant sucralfate‐warfarin interaction is not likely [letter]. British Journal of Clinical Pharmacology 20:2, pages 178-180.
Crossref
Katherine M. McGrath, Robert W. Herrington, Peter J. Turner, Peter Schiff, Kathrin B. Thomas, Lindsay Taylor, Henry Ekert & Ian D. Gust. (1985) Use of heat‐treated clotting‐factor concentrates in patients with haemophilia and a high exposure to HTLV‐III. Medical Journal of Australia 143:1, pages 11-13.
Crossref
Henrik E. Poulsen, Anette Lerche & Niels T. Pedersen. (1985) Potentiated hepatotoxicity from concurrent administration of acetaminophen and allyl alcohol to rats. Biochemical Pharmacology 34:6, pages 727-731.
Crossref
Cynthia A de Wit, Gertie Persson, Inga Marie Nilsson & Bengt W Johansson. (1985) Circannual changes in blood coagulation factors and the effect of warfarin on the hedgehog Erinaceus europaeus. Comparative Biochemistry and Physiology Part A: Physiology 80:1, pages 43-47.
Crossref
Yoshihiro Fujimura, Noriko Nakaue, Mitsuhiko Sugimoto, Ikuko Matsuyama, Toshio Takase, Akira Yoshioka & Hiromu Fukui. (2007) Congenital Hypoprothrombinemia: The First Reported Case in Japan. Pediatrics International 26:4, pages 554-560.
Crossref
E. Tvedegaard, H. E. Poulsen, H. Vilstrup & H. K. Thomsen. (1984) Liver function during chronic renal failure in rabbits. Experientia 40:11, pages 1255-1256.
Crossref
Lars Wilhelmsen, Kurt Svärdsudd, Kristoffer Korsan-Bengtsen, Bo Larsson, Lennart Welin & Gösta Tibblin. (1984) Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction. New England Journal of Medicine 311:8, pages 501-505.
Crossref
H.C. Hemker, M.C.E. van Dam-Mieras & P.P. Devilée. (1984) The action of echis carinatus venom on the blood coagulation system. Demonstration of an activator of factor X. Thrombosis Research 35:1, pages 1-9.
Crossref
H. E. Poulsen & B. Korsholm. (2009) Quantitative Liver Functions after Administration of Allyl Alcohol to Rats. Acta Pharmacologica et Toxicologica 54:2, pages 120-123.
Crossref
R. A. Yanofsky, V. G. Jackson, J. R. Lilly, G. Stellin, W. C. KlingensmithIIIIII & W. E. Hathaway. (2006) The multiple coagulopathies of biliary atresia. American Journal of Hematology 16:2, pages 171-180.
Crossref
A Gårde, K Samuelsson, H Fahlgren, E Hedberg, L G Hjerne & J Ostman. (1983) Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation.. Stroke 14:5, pages 677-681.
Crossref
Michael R. Owens & Catherine D. Cimino. (1983) The interaction of salicylate and vitamin K in synthesis of factor II (prothrombin). Thrombosis Research 31:1, pages 135-143.
Crossref
Derek OgstonDerek Ogston. 1983. The Physiology of Hemostasis. The Physiology of Hemostasis
219
248
.
Gary C. Kanel, George Radvanand & Robert L. Peters. (2007) High-Density Lipoprotein Cholesterol and Liver Disease. Hepatology 3:3, pages 343-348.
Crossref
. (2009) Abnormal Plasma Prothrombin In The Diagnosis Of Subclinical Vitamin K Deficiency. Nutrition Reviews 40:10, pages 298-300.
Crossref
James J. CorriganJr.Jr.. (2006) THE EFFECT OF VITAMIN E ON WARFARIN‐INDUCED VITAMIN K DEFICIENCY*. Annals of the New York Academy of Sciences 393:1, pages 361-368.
Crossref
F. RUIZ, S. L. GRAINGER, R. J. C. HALL, G. I. C. INGRAM, V. POLLARD & A. V. SWAN. (2008) Relation of simple clotting tests to clotting factor levels in liver disease. Clinical & Laboratory Haematology 4:3, pages 247-256.
Crossref
Herman E. Branson, Naveen Gupta, Lewis M. Slater, Awilda Fagin & Steven A. Armentrout. (2006) Activated partial thromboplastin time after heparin removal (aPTT/HR) in a new scheme of anticoagulant monitoring. American Journal of Hematology 12:4, pages 411-418.
Crossref
J. Lindskov. (2009) The Quantitative Liver Function as Measured by the Galactose Elimination Capacity. Acta Medica Scandinavica 212:5, pages 295-302.
Crossref
M. BAHNSEN, C. GLUUD, S. G. JOHNSEN, P. BENNETT, S. SVENSTRUP, S. MICIC, O. DIETRICHSON, L. B. SVENDSEN & U. A. BRODTHAGEN. (2008) Pituitary‐testicular function in patients with alcoholic cirrhosis of the liver. European Journal of Clinical Investigation 11:6, pages 473-479.
Crossref
S. I. YILDIRIM & H. E. POULSEN. (2008) Quantitative liver functions after 70% hepatectomy. European Journal of Clinical Investigation 11:6, pages 469-472.
Crossref
E.B. Pivorun & W.B. Sinnamon. (1981) Blood coagulation studies in normothermic, hibernating, and aroused Spermophilus franklini. Cryobiology 18:5, pages 515-520.
Crossref
J J CorriganJrJr & L L Ulfers. (1981) Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency. The American Journal of Clinical Nutrition 34:9, pages 1701-1705.
Crossref
Pekka Lähteenmäki, Vesa Rasi, Tapani Luukkainen & Gunnar Myllyä. (1981) Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion. American Journal of Obstetrics and Gynecology 141:2, pages 175-179.
Crossref
James J. CorriganJr.Jr., Lynn M. Taussig, Robert Beckerman & Jeffrey S. Wagener. (1981) Factor II (prothrombin) coagulant activity and immunoreactive protein: Detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. The Journal of Pediatrics 99:2, pages 254-257.
Crossref
Y A Kesaniemi, T A Miettinen & M P Salaspuro. (1981) Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes.. Gut 22:7, pages 579-584.
Crossref
Lilian Tengborn, S. Anders Larsson, Ulla Hedner & Inga Marie Nilsson. (2009) Coagulation studies in children and young adults with cerebral ischemic episodes. Acta Neurologica Scandinavica 63:6, pages 351-361.
Crossref
H. E. POULSEN, P. PETERSEN & H. VILSTRUP. (2008) Quantitative liver function and morphology after paracetamol administration to rats. European Journal of Clinical Investigation 11:3, pages 161-164.
Crossref
H. A. Pattinson, P. R. Koninckx, I. A. Brosens & J. Vermylen. (2005) CLOTTING AND FIBRINOLYTIC ACTIVITIES IN PERITONEAL FLUID. BJOG: An International Journal of Obstetrics & Gynaecology 88:2, pages 160-166.
Crossref
B. Connor Johnson. (1981) Post-translational carboxylation of preprothrombin. Molecular and Cellular Biochemistry 38:1, pages 77-121.
Crossref
B. Connor Johnson. 1982. The Biological Effects of Glutamic Acid and Its Derivatives. The Biological Effects of Glutamic Acid and Its Derivatives
77
121
.
D. R. Barnard, R. G. Chapman, M. A. Simmons & W. E. Hathaway. (2003) Blood for Use in Exchange Transfusion in the Newborn. Transfusion 20:4, pages 401-408.
Crossref
James J. CorriganJr.Jr. & David L. Earnest. (2006) Factor II antigen in liver disease and warfarin‐induced vitamin K deficiency: Correlation with coagulant activity using echis venom. American Journal of Hematology 8:3, pages 249-255.
Crossref
C. A. Johnson, K. S. Chung, K. M. McGrath, P. E. Bean & H. R. Roberts. (2008) Characterization of a Variant Prothrombin in a Patient Congenitally Deficient in Factors II, VII, IX and X. British Journal of Haematology 44:3, pages 461-469.
Crossref
F. W. Peuscher, W. G. Aken, J. A. Mourik, A. J. G. Swaak, L. H. Sie & L.W. Statius Eps. (2009) Acquired, Transient Factor X (Stuart Factor) Deficiency in a Patient with Mycoplasma Pneumonial Infection. Scandinavian Journal of Haematology 23:4, pages 257-264.
Crossref
Kathryn A. E. Whigham, P. W. Howie, Alison Mack & C. R. M. Prentice. (2005) THE EFFECT OF AN lNJECTABLE PROGESTOGEN CONTRACEPTIVE ON BLOOD COAGULATION AND FIBRINOLYSIS. BJOG: An International Journal of Obstetrics & Gynaecology 86:10, pages 806-809.
Crossref
J Dyerberg & H.O Bang. (1979) HÆMOSTATIC FUNCTION AND PLATELET POLYUNSATURATED FATTY ACIDS IN ESKIMOS. The Lancet 314:8140, pages 433-435.
Crossref
M.M.P. Paulssen, A. Kolhorn, J. Rothuizen & M.C. Planje. (1979) An automated amidolytic assay of thrombin generation: An alternative for the prothrombin-time test. Clinica Chimica Acta 92:3, pages 465-468.
Crossref
B.R.J. Kirchhof, A.D. Muller & H.C. Hemker. (1979) An inhibitor of clot formation in cord plasma. Thrombosis Research 15:3-4, pages 389-403.
Crossref
Mogens Sandbjerg Hansen, O. Behnke, N. Tinggaard Pedersen & Aage Videbæk. (2009) Megathrombocytopenia Associated with Glomerulonephritis, Deafness and Aortic Cystic Medianecrosis. Scandinavian Journal of Haematology 21:3, pages 197-205.
Crossref
G. K. Osbourne, K. A. E. Whigham, P. W. Howie, P. England, A. Kelly & C. R. M. Prentice. (2005) THE EFFECTS OF QUINESTROL AND BROMOCRIPTINE ON BLOOD COAGULATION, SERUM PROLACTIN AND SERUM FSH LEVELS IN PUERPERAL WOMEN. BJOG: An International Journal of Obstetrics & Gynaecology 85:9, pages 687-691.
Crossref
David Easa. (1978) Coagulation abnormalities associated with localized hemorrhage in the neonate. The Journal of Pediatrics 92:6, pages 989-994.
Crossref
A. Henricsson, Ulla Hedner & S.-E. Bergentz. (1978) The effect of ALG on coagulation and fibrinolysis. Thrombosis Research 12:6, pages 1099-1112.
Crossref
A. Criel, D. Collen & P.L. Masson. (1978) A case of IgM antibodies which inhibit the contact activation of blood coagulation. Thrombosis Research 12:5, pages 883-892.
Crossref
C. Vermeer, B.A.M. Soute & H.C. Hemker. (1978) Improvements of the method for the preparation of an artificial prothrombin reagent. Thrombosis Research 12:4, pages 713-716.
Crossref
M.J. Lindhout, B.H.M. Kop-Klaassen, J.M.M. Kop & H.C. Hemker. (1978) Purification and properties of the phenprocoumon-induced decarboxyfactor X from bovine plasma. Biochimica et Biophysica Acta (BBA) - Protein Structure 533:2, pages 302-317.
Crossref
Lilian Johansson, Ulla Hedner & Inga Marie Nilsson. (2009) A Family with Thromboembolic Disease Associated with Deficient Fibrinolytic Activity in Vessel Wall. Acta Medica Scandinavica 203:1-6, pages 477-480.
Crossref
Lilian Johansson, Ulla Hedner & Inga Marie Nilsson. (2009) Familial Antithrombin III Deficiency as Pathogenesis of Deep Venous Thrombosis. Acta Medica Scandinavica 204:1-6, pages 491-495.
Crossref
Robert E. Olson & John W. Suttie. 1978.
59
108
.
Rolf RauRolf Rau & D. Gross. 1978. Die Leber Bei Entzündlichen Rheumatischen Erkrankungen. Die Leber Bei Entzündlichen Rheumatischen Erkrankungen
6
47
.
Charles D. Lox, G. Henry Strohm & James J. CorriganJrJr. (2006) Radioimmunoassay of human prothrombin—The quantitation of plasma factor II antigen. American Journal of Hematology 4:3, pages 261-267.
Crossref
LEENA TUDERMAN, JUHA RISTELI, TATU A. MIETTINEN & KARI I. KIVIRIKKO. (2008) Serum immunoreactive prolyl hydroxylase in liver disease. European Journal of Clinical Investigation 7:6, pages 537-541.
Crossref
Mark J. Morton, John H. McAnulty, Shahbudin H. Rahimtoola & Naina Ahuja. (1977) Risks and benefits of postoperative cardiac catheterization in patients with ball valve prostheses. The American Journal of Cardiology 40:6, pages 870-875.
Crossref
P. Bhanchet, S. Tuchinda, P. Hathirat, P. Visudhiphan, N. Bhamaraphavati & S. Bukkavesa. (2016) A Bleeding Syndrome in Infants due to Acquired Prothrombin Complex Deficiency. Clinical Pediatrics 16:11, pages 992-998.
Crossref
DM Davies, MD Rawlins & PA Routledge. (2012) Factors affecting anticoagulant response [proceedings]. British Journal of Clinical Pharmacology 4:5.
Crossref
S Husted & F Andreasen. (2012) The influence of age on the response to anticoagulants.. British Journal of Clinical Pharmacology 4:5, pages 559-565.
Crossref
M. Verstraete, J. Vermylen, W. Holleman & G.H. Barlow. (1977) Biological effects of the administration of an equimolar streptokinase-plasminogen complex in man. Thrombosis Research 11:2, pages 227-236.
Crossref
N. Semeraro & J. Vermylen. (2008) Evidence that Washed Human Platelets Possess Factor‐X Activator Activity. British Journal of Haematology 36:1, pages 107-115.
Crossref
N. Refsum, H. Arnesen, C. C. Gilhuus‐Moe & H. C. Godal. (2009) The Relationship between Normotest and Thrombotest in Patients on Oral Anticoagulant Therapy. Scandinavian Journal of Haematology 18:4, pages 333-336.
Crossref